Variant report
Variant | esv3350147 |
---|---|
Chromosome Location | chr1:228254679-228260227 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:19)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:19 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:228246811..228249127-chr1:228257869..228259965,2 | MCF-7 | breast: | |
2 | chr1:228191350..228193786-chr1:228257693..228259549,2 | MCF-7 | breast: | |
3 | chr1:228196561..228199539-chr1:228260175..228262293,2 | MCF-7 | breast: | |
4 | chr1:228252404..228256168-chr1:228256803..228260253,5 | MCF-7 | breast: | |
5 | chr1:228189312..228191341-chr1:228252791..228255165,2 | MCF-7 | breast: | |
6 | chr1:228256397..228258359-chr1:228260087..228261703,2 | MCF-7 | breast: | |
7 | chr1:228249620..228252604-chr1:228254168..228256020,2 | MCF-7 | breast: | |
8 | chr1:228252333..228254896-chr1:228269798..228271614,2 | MCF-7 | breast: | |
9 | chr1:228256397..228258359-chr1:228260087..228261703,2 | MCF-7 | breast: | |
10 | chr1:228186754..228188818-chr1:228253056..228255508,2 | MCF-7 | breast: | |
11 | chr1:228230109..228232010-chr1:228259554..228261382,2 | MCF-7 | breast: | |
12 | chr1:228248925..228252171-chr1:228258918..228261969,3 | MCF-7 | breast: | |
13 | chr1:228187251..228191319-chr1:228259829..228263819,5 | MCF-7 | breast: | |
14 | chr1:228249900..228252116-chr1:228255479..228257281,2 | MCF-7 | breast: | |
15 | chr1:228257466..228261450-chr1:228360954..228363878,3 | K562 | blood: | |
16 | chr1:228259486..228261831-chr1:228263458..228267215,4 | MCF-7 | breast: | |
17 | chr1:228252404..228256168-chr1:228256803..228260253,5 | MCF-7 | breast: | |
18 | chr1:228255167..228256688-chr5:676745..679087,2 | K562 | blood: | |
19 | chr1:228251281..228254071-chr1:228258113..228259786,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000143761 | chromatin interactions |
ENSG00000181873 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556379538 | chr1:228254716-228254717 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs529331329 | chr1:228254735-228254736 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs142354222 | chr1:228254736-228254737 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs560243882 | chr1:228254746-228254747 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs12161517 | chr1:228254753-228254754 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs542225136 | chr1:228254773-228254774 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs562428043 | chr1:228254810-228254811 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs529544103 | chr1:228254817-228254818 | Bivalent Enhancer Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs550802155 | chr1:228254918-228254919 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78627368 | chr1:228254934-228254935 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369277211 | chr1:228254935-228254936 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533303156 | chr1:228254943-228254944 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376212746 | chr1:228254960-228254961 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376820501 | chr1:228254972-228254973 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537675997 | chr1:228254979-228254980 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551466256 | chr1:228254989-228254990 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145925726 | chr1:228255019-228255020 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139656496 | chr1:228255034-228255035 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555451995 | chr1:228255039-228255040 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73092912 | chr1:228255063-228255064 | Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs537742633 | chr1:228255080-228255081 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556446711 | chr1:228255159-228255160 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577918826 | chr1:228255176-228255177 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538797797 | chr1:228255238-228255239 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185018056 | chr1:228255269-228255270 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144564170 | chr1:228255271-228255272 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148451965 | chr1:228255325-228255326 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560711504 | chr1:228255341-228255342 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371249076 | chr1:228255356-228255357 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs544506262 | chr1:228255428-228255429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs10916263 | chr1:228255433-228255434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113062093 | chr1:228255504-228255505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533361433 | chr1:228255554-228255555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145202405 | chr1:228255567-228255568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375727594 | chr1:228255576-228255577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375609730 | chr1:228255610-228255611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545943414 | chr1:228255643-228255644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527770405 | chr1:228255652-228255653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549399279 | chr1:228255659-228255660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189039107 | chr1:228255671-228255672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34873689 | chr1:228255697-228255698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376440280 | chr1:228255718-228255719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2760066 | chr1:228255729-228255730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112900924 | chr1:228255746-228255747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs2760065 | chr1:228255756-228255757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550111901 | chr1:228255800-228255801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571534590 | chr1:228255869-228255870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185113389 | chr1:228255890-228255891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189571565 | chr1:228255942-228255943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572143869 | chr1:228255944-228255945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
Myelofibrosis | 22110671 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:228248200-228269000 | Weak transcription | Right Atrium | heart |
2 | chr1:228254000-228255000 | Enhancers | Placenta | Placenta |
3 | chr1:228254000-228255000 | Bivalent Enhancer | Fetal Stomach | stomach |
4 | chr1:228254600-228254800 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
5 | chr1:228254600-228254800 | Bivalent Enhancer | Stomach Mucosa | stomach |
6 | chr1:228254600-228255400 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr1:228255200-228255400 | Bivalent Enhancer | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr1:228255200-228255400 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr1:228256400-228256600 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
10 | chr1:228256400-228257000 | Bivalent/Poised TSS | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr1:228258400-228258600 | Bivalent Enhancer | Brain Germinal Matrix | brain |
12 | chr1:228258400-228258600 | Enhancers | Esophagus | oesophagus |
13 | chr1:228258600-228269000 | Weak transcription | Esophagus | oesophagus |
14 | chr1:228259600-228262000 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
15 | chr1:228260000-228260200 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
16 | chr1:228260000-228260200 | Enhancers | Brain Inferior Temporal Lobe | brain |
17 | chr1:228260000-228260200 | Enhancers | Spleen | Spleen |
18 | chr1:228260000-228260800 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
19 | chr1:228260200-228260600 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr1:228260200-228261800 | Weak transcription | Spleen | Spleen |
21 | chr1:228260200-228268000 | Weak transcription | Gastric | stomach |
22 | chr1:228260200-228269000 | Weak transcription | Brain Inferior Temporal Lobe | brain |